Racial Differences in Quality of Life in Patients With Heart Failure Treated With Sodium-Glucose Cotransporter 2 Inhibitors: A Patient-Level Meta-Analysis of the CHIEF-HF, DEFINE-HF, and PRESERVED-HF Trials.
Kashvi GuptaJohn A SpertusMary BirminghamKensey L GoschMansoor HusainDalane W KitzmanBertram PittSanjiv J ShahJames L JanuzziIldiko LingvayJaved ButlerMikhail Naum KosiborodDavid E LanfearPublished in: Circulation (2023)
Treatment with an SGLT2i resulted in consistent and significant improvements in health status for both Black and White patients with heart failure.